Alex Colville
Fondatore presso Age 1
Profilo
Alex Colville is the founder of age1 Capital Management LLC, which was founded in 2023.
Dr. Colville's former jobs include Associate Consultant at Putnam Associates LLC from 2014 to 2016, Consultant at Maze Therapeutics, Inc. from 2020 to 2021, Consultant at Rubedo Life Sciences, Inc. from 2019 to 2021, Founding Chief of Staff at Amaranth Foundation from 2021 to 2023, and Investment Manager at Starbloom Capital LP from 2021 to 2023.
Dr. Colville's education includes a doctorate degree from Stanford University in 2021 and an undergraduate degree from Northeastern University in 2015.
Posizioni attive di Alex Colville
Società | Posizione | Inizio |
---|---|---|
Age 1
Age 1 Investment ManagersFinance age1 Capital Management LLC (age1) is a venture capital firm founded in 2023 by Alex Colville and Laura Deming. The firm is headquartered in San Francisco, California. | Fondatore | 01/01/2023 |
Precedenti posizioni note di Alex Colville
Società | Posizione | Fine |
---|---|---|
Starbloom Capital LP | Investitore di Private Equity | 01/01/2023 |
Amaranth Foundation | Ufficiale delle Risorse Umane | 01/01/2023 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Consulente / Consigliere | 01/05/2021 |
Rubedo Life Sciences, Inc.
Rubedo Life Sciences, Inc. Packaged SoftwareTechnology Services Rubedo Life Sciences, Inc. develops intelligent drug platform to design unique, targeted and controlled therapies for age-related diseases. The company was founded by Marco Quarta, Mark Gallop and Julian Klein in 2018 and is headquartered in Silicon Valley, CA. | Consulente / Consigliere | 01/05/2021 |
Putnam Associates LLC
Putnam Associates LLC Miscellaneous Commercial ServicesCommercial Services Putnam Associates LLC engages in the provision of strategic consulting serving biopharmaceutical, diagnostics, and medical device clients. It specializes in corporate strategy, portfolio licensing and development strategy, new product, established products and franchise strategy, pricing, reimbursement and market access, and other related strategic projects. The company was founded by Kevin J. Gorman in 1988 and is headquartered in Boston, MA. | Consulente / Consigliere | 01/08/2016 |
Formazione di Alex Colville
Stanford University | Doctorate Degree |
Northeastern University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
Putnam Associates LLC
Putnam Associates LLC Miscellaneous Commercial ServicesCommercial Services Putnam Associates LLC engages in the provision of strategic consulting serving biopharmaceutical, diagnostics, and medical device clients. It specializes in corporate strategy, portfolio licensing and development strategy, new product, established products and franchise strategy, pricing, reimbursement and market access, and other related strategic projects. The company was founded by Kevin J. Gorman in 1988 and is headquartered in Boston, MA. | Commercial Services |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Commercial Services |
Rubedo Life Sciences, Inc.
Rubedo Life Sciences, Inc. Packaged SoftwareTechnology Services Rubedo Life Sciences, Inc. develops intelligent drug platform to design unique, targeted and controlled therapies for age-related diseases. The company was founded by Marco Quarta, Mark Gallop and Julian Klein in 2018 and is headquartered in Silicon Valley, CA. | Technology Services |
Age 1
Age 1 Investment ManagersFinance age1 Capital Management LLC (age1) is a venture capital firm founded in 2023 by Alex Colville and Laura Deming. The firm is headquartered in San Francisco, California. | Finance |
Amaranth Foundation | |
Starbloom Capital LP |
- Borsa valori
- Insiders
- Alex Colville